Product logins

Find logins to all Clarivate products below.


Clarivate’s Pharma Industry Report provides pharma executives with a comprehensive summary of the current and future state of the global pharmaceutical industry.

Scope

This report pulls together key information about the global pharmaceutical market from across our Company & Drug Insights content. We analyze the top selling brands, companies, and therapeutic areas. We evaluate the leading competitors in terms of their ethical drug sales, strategic focus, current drivers, patent exposure, and pipeline projects. We compare the different therapeutic areas in terms of their global sales and highlight the leading competitors and pipeline drugs within each area to provide you with a comprehensive summary of the global market.

Companies Mentioned

  • AbbVie
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi-Sankyo
  • Eisai
  • Eli Lilly
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
  • Teva
  • Vertex

Questions answered in this report

  • Who are the leading competitors in the global pharmaceutical industry? What are their current drivers and areas of R&D? What is their timeline for patent exposure?
  • How do the different therapy areas rank in terms of size and relative growth? How do their global sales break down by drug technology, and what are the leading pipeline projects?
  • What are the leading drugs according to global sales, and how will these rankings change by 2028?

 

Related Market Assessment Reports

Report
Systemic Lupus Erythematosus – Access & Reimbursement – Access & Reimbursement – Systemic Lupus Erythematosus (US)
The U.S. systemic lupus erythematosus (SLE) therapy market is largely genericized and off-label. With the exception of GSK’s Benlysta, the firstagents approved for the indication in almost 60…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Reduced Ejection Fraction (US)
Heart failure with reduced ejection fraction (HFrEF) occurs when the left ventricular ejection fraction (LVEF) is 40% or less. Drug treatment for HFrEF is well established and supported by…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Preserved Ejection Fraction (US)
Heart failure with preserved ejection fraction (HFpEF) occurs when the left ventricular ejection fraction (LVEF) is 50% or more. Even though physicians’ understanding of the disease’s…
Report
Membranous Nephropathy – Landscape & Forecast – Disease Landscape & Forecast (G7)
Primary membranous nephropathy (pMN), the most common type of MN, is a rare autoantibody-mediated autoimmune kidney disease. Although it is one of the leading causes of nephrotic syndrome in…
Report
Irritable Bowel Syndrome – Current Treatment – Treatment Algorithms – Claims Data Analysis – IBS-Diarrhea (US)
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. The disorder is grouped into three…